Market Place
Sourcing Support
Alphamab to Present Chinese Clinical Data of JSKN003 for HER2-exp. Solid Tumors
06 May 2024 //
ASIAONE
Alphamab Oncology Reports Full Year 2021 Financial Results
30 Mar 2022 //
PRNEWSWIRE
IND Approved for Pivotal Clinical Study of HER2 Bispecific Antibody KN026
05 Jan 2022 //
ASIAONE
Alphamab Announces First Patient Dosed in the Pivotal Clinical Study of KN046
29 Oct 2021 //
ALPHAMABONC
Alphamab partners in $150m licensing deal; Pfizer to join lawsuit on tariffs
26 Aug 2021 //
ENDPTS
Alphamab Presents Phase 2 Clinical Data on KN046 at ASCO 2021
07 Jun 2021 //
PRESS RELEASE
Alphamab Oncology to Present Multiple Clinical Research Data at the 2021 ASCO
20 May 2021 //
ASIAONE
Alphamab Oncology Presented Clinical Data of KN046 Combined with Nab-paclitaxel
13 Apr 2021 //
PRNASIA
Alphamab Received U.S. FDA IND Clearance to Initiate A Phase II
09 Mar 2021 //
PRNEWSWIRE
Alphamab Received U.S. FDA IND Clearance to Initiate A Phase II Clinical Trial
09 Mar 2021 //
PRNASIA
TRACON Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA
30 Dec 2020 //
GLOBENEWSWIRE
TRACON Pharmaceuticals Highlights Updated Envafolimab Clinical Results
21 Sep 2020 //
GLOBENEWSWIRE
Alphamab Oncology announced that FDA granted orphan drug designation to KN046
03 Sep 2020 //
PRNASIA
Janssen to stop clinical development of pimodivir for influenza
03 Sep 2020 //
PRNASIA
Alphamab, Sanofi collaborate for breast cancer research
17 Jun 2020 //
BIOSPECTRUMASIA
Sanofi sharpens focus on bispecifics, and China, with Alphamab deal
10 Jun 2020 //
ENDPTS
Collaborating in Innovative Medical R&D to combat the pandemic, Alphamab
09 Jun 2020 //
PRNASIA
Alphamab Oncology and Sanofi Enter Collaboration on KN026 in HER2+ Breast Cancer
08 Jun 2020 //
PRNASIA
TRACON Announces Presentation of Positive Clinical Data for Envafolimab
14 May 2020 //
GLOBENEWSWIRE
Alphamab Oncology Received USFDA IND Approval to Initiate A PhII KN046
16 Apr 2020 //
PR NEWSWIRE
Alphamab Oncology Announces Clinical Supply Collaboration with Pfizer on KN026
27 Mar 2020 //
PR NEWSWIRE
Alphamab Oncology rounds out HKEX`s second biotech IPO year with $230M raise
12 Dec 2019 //
ENDPTS
Alphamab Oncology rounds out HKEX`s second biotech IPO year with $230M raise
12 Dec 2019 //
ENDPTS
Pharma Companies Set to Raise $5 Billion in Hong Kong IPOs in 2019
10 Dec 2019 //
BLOOMBERG
Henlius Biotech shrugs off Hong Kong disruption with $477M IPO bid
13 Sep 2019 //
PHARMAPHORUM
Fast moving Chinese regulators wave third homegrown PD-1 to market
01 Jun 2019 //
ENDPTS
Ready to harvest its PD-L1, Alphamab reloads with $60M bispecific patch
29 May 2019 //
ENDPTS
Alphamab completes $60 M Series B Financing
28 May 2019 //
BIOSPECTRUMASIA
Alphamab Oncology loads up $100M-plus from marquee backers
20 Nov 2018 //
ENDPTS
Alphamab starts phase I clinical trial in Australia
11 Oct 2018 //
BIOSPECTRUM
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.